Literature DB >> 16284293

Severe recurrent Crohn's disease of the ileocolonic anastomosis disappearing completely with antibacterial therapy.

P R Elliott, G T C Moore, S J Bell, W R Connell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16284293      PMCID： PMC1774812          DOI： 10.1136/gut.2005.078568

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  10 in total

1.  Preliminary study of ciprofloxacin in active Crohn's disease.

Authors:  George L Arnold; Mary R Beaves; Vladimir O Pryjdun; William J Mook
Journal:  Inflamm Bowel Dis       Date:  2002-01       Impact factor: 5.325

2.  The efficacy of azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in patients with Crohn's disease remains uncertain.

Authors:  William J Sandborn; Brian G Feagan
Journal:  Gastroenterology       Date:  2004-09       Impact factor: 22.682

3.  Predictability of the postoperative course of Crohn's disease.

Authors:  P Rutgeerts; K Geboes; G Vantrappen; J Beyls; R Kerremans; M Hiele
Journal:  Gastroenterology       Date:  1990-10       Impact factor: 22.682

4.  Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease.

Authors:  Christel Neut; Philippe Bulois; Pierre Desreumaux; Jeanne-Marie Membré; Emmanuel Lederman; Luc Gambiez; Antoine Cortot; Pierre Quandalle; Herbert van Kruiningen; Jean-Fredéric Colombel
Journal:  Am J Gastroenterol       Date:  2002-04       Impact factor: 10.864

5.  Controlled trial of metronidazole treatment for prevention of Crohn's recurrence after ileal resection.

Authors:  P Rutgeerts; M Hiele; K Geboes; M Peeters; F Penninckx; R Aerts; R Kerremans
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

6.  Natural course of Crohn's disease after ileocolic resection: endoscopically visualised ileal ulcers preceding symptoms.

Authors:  G Olaison; K Smedh; R Sjödahl
Journal:  Gut       Date:  1992-03       Impact factor: 23.059

7.  Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul Rutgeerts; Gert Van Assche; Séverine Vermeire; Geert D'Haens; Filip Baert; Maja Noman; Isolde Aerden; Gert De Hertogh; Karel Geboes; Martin Hiele; Andre D'Hoore; Freddy Penninckx
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

8.  Long-term treatment of ulcerative colitis with ciprofloxacin: a prospective, double-blind, placebo-controlled study.

Authors:  U M Turunen; M A Färkkilä; K Hakala; K Seppälä; A Sivonen; M Ogren; M Vuoristo; V V Valtonen; T A Miettinen
Journal:  Gastroenterology       Date:  1998-11       Impact factor: 22.682

9.  Combined budesonide and antibiotic therapy for active Crohn's disease: a randomized controlled trial.

Authors:  A Hillary Steinhart; Brian G Feagan; Cindy J Wong; Margaret Vandervoort; Shelley Mikolainis; Kenneth Croitoru; Ernest Seidman; Desmond J Leddin; Alain Bitton; Eric Drouin; Albert Cohen; Gordon R Greenberg
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

10.  High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease.

Authors:  Arlette Darfeuille-Michaud; Jérôme Boudeau; Philippe Bulois; Christel Neut; Anne-Lise Glasser; Nicolas Barnich; Marie-Agnès Bringer; Alexander Swidsinski; Laurent Beaugerie; Jean-Frédéric Colombel
Journal:  Gastroenterology       Date:  2004-08       Impact factor: 22.682
  10 in total
  1 in total

1.  A new animal model of postsurgical bowel inflammation and fibrosis: the effect of commensal microflora.

Authors:  R J Rigby; M R Hunt; B P Scull; J G Simmons; K E Speck; M A Helmrath; P K Lund
Journal:  Gut       Date:  2009-04-26       Impact factor: 23.059
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.